March 1, 2018 – Removing barriers so individuals struggling with the disease of addiction can access treatment should be a goal for policymakers. Identifying effective and evidence-based methods for treatment – like Malvern Institute utilizes – will assist individuals to begin the recovery process.
The U.S. Food and Drug Administration is expected to bolster medication-assisted treatment options through new guidelines, according to WHYY. These medications could ease withdrawal symptoms and cravings for individuals struggling with addiction:
The new FDA guidelines are part of its strategy for promoting drugs that can ease withdrawal symptoms and cravings for people addicted to opioids.
The guidelines would make it easier to get new medications approved that are shown to help in some way with a patient’s recovery, even if the person doesn’t stop using drugs completely.
“This is moving us in the right direction, but there are a slew of effective drugs that are already out there,” said Dr. Geoffrey Neimark, the chief medical officer for Community Behavioral Health, which runs Philadelphia’s network of addiction treatment providers for people on Medicaid.
Malvern Institute: We Give Hope
Read the full story from WHYY.